KETAMINE HYDROCHLORIDE (ketamine hydrochloride) by Fresenius Kabi is injection, a racemic mixture of ketamine, is a non-selective, non-competitive antagonist of the n-methyl-d-aspartate (nmda) receptor, an ionotropic glutamate receptor. First approved in 2023.
Drug data last refreshed 9h ago
Injection, a racemic mixture of ketamine, is a non-selective, non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor, an ionotropic glutamate receptor. The major circulating metabolite of ketamine (norketamine) demonstrated activity at the same receptor with less affinity.…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Fresenius Kabi is hiring 10 roles related to this product
Worked on KETAMINE HYDROCHLORIDE at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.